BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND HLF, Q16534, 3131, ENSG00000108924
7 results:

  • 1. hlf promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway.
    Han T; Chen T; Chen L; Li K; Xiang D; Dou L; Li H; Gu Y
    Cell Death Dis; 2023 Sep; 14(9):606. PubMed ID: 37709768
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. hlf regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.
    Li H; Yang P; Wang J; Zhang J; Ma Q; Jiang Y; Wu Y; Han T; Xiang D
    J Hematol Oncol; 2022 Jan; 15(1):2. PubMed ID: 34991659
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Performance Comparison of Commonly Used Assays to Detect RET Fusions.
    Yang SR; Aypar U; Rosen EY; Mata DA; Benayed R; Mullaney K; Jayakumaran G; Zhang Y; Frosina D; Drilon A; Ladanyi M; Jungbluth AA; Rekhtman N; Hechtman JF
    Clin Cancer Res; 2021 Mar; 27(5):1316-1328. PubMed ID: 33272981
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression.
    Fei Z; Lijuan Y; Jing Z; Xi Y; Yuefen P; Shuwen H
    Hum Cell; 2021 Jan; 34(1):177-186. PubMed ID: 32936424
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Oncofetal hlf transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance.
    Xiang DM; Sun W; Zhou T; Zhang C; Cheng Z; Li SC; Jiang W; Wang R; Fu G; Cui X; Hou G; Jin GZ; Li H; Hou C; Liu H; Wang H; Ding J
    Gut; 2019 Oct; 68(10):1858-1871. PubMed ID: 31118247
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Predictive role of nontumoral sodium iodide symporter activity and preoperative thyroid characteristics in remission process of thyroid cancer patients.
    Yildirim-Poyraz N; Yazgan A; Ozdemir E; Gozalan A; Keskin M; Ersoy R; Turkolmez S; Cakir B
    Ann Nucl Med; 2014 Aug; 28(7):623-31. PubMed ID: 24823701
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Assessment of protein kinase C isozymes by enzyme immunoassay and overexpression of type II in thyroid adenocarcinoma.
    Hagiwara M; Hachiya T; Watanabe M; Usuda N; Iida F; Tamai K; Hidaka H
    Cancer Res; 1990 Sep; 50(17):5515-9. PubMed ID: 1696850
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.